Stantec
STN
66.67
-0.87
-1.29%
Stantec
US · STN
#1716 by market cap
Listed 1970
66.67
-0.87
-1.29%
Live - 5344 symbols - heartbeat 295s ago
· 2026-10-08 04:00
Pre-market
66.67
0.00%
After-hours
66.67
0.00%
- Market cap
- 7.49B
- P/E (TTM)i
- 21.46
- P/Bi
- 3.15
- EPSi
- 2.95
- Div yieldi
- 0.99%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on STN?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.66, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.59% YoY
Margins
- Gross margin
- 43.33%
- Operating margin
- 8.84%
- Net margin
- 5.89%
Key ratios & quality
- Enterprise valuei
- 9.04B
- PEG ratioi
- 0.87
- Altman Z-Scorei
- 2.66
PEG uses trailing P/E against the 3-year net income growth rate (24.74%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.28B | 4.83B | 4.73B | 4.58B | 5.68B | 6.48B | 7.50B | 8.14B |
| Gross profit | 1.82B | 2.01B | 1.93B | 1.96B | 2.42B | 2.74B | 3.20B | 3.53B |
| Selling & admin expenses | 1.44B | 1.43B | 1.35B | 1.42B | 1.74B | 1.97B | 2.29B | 2.46B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 261.90M | 333.90M | 348.80M | 317.90M | 391.30M | 495.80M | 591.00M | 719.80M |
| Pretax profit | 226.30M | 265.50M | 216.70M | 263.00M | 325.10M | 407.70M | 465.30M | 630.00M |
| Tax | 55.00M | 71.10M | 57.60M | 62.30M | 78.10M | 91.20M | 103.80M | 150.60M |
| Net profit | 47.40M | 194.40M | 171.10M | 200.70M | 247.00M | 316.50M | 361.50M | 479.40M |
| Basic EPS | 0 | 2 | 2 | 2 | 2 | 3 | 3 | 4 |
| Diluted EPS | 0.42 | 1.74 | 1.53 | 1.80 | 2.22 | 2.85 | 3.17 | 4.20 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.92B | 1.96B | 2.14B | 2.12B | 2.07B | 2.23B |
| Gross profit | 843.50M | 864.70M | 927.90M | 892.90M | 914.10M | 970.70M |
| Selling & admin expenses | 612.00M | 598.30M | 616.00M | 631.20M | 648.30M | 648.20M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 153.00M | 186.70M | 221.90M | 158.20M | 171.00M | 228.80M |
| Pretax profit | 130.00M | 179.10M | 198.80M | 122.10M | 146.60M | 200.10M |
| Tax | 29.90M | 43.70M | 48.80M | 28.20M | 35.80M | 49.80M |
| Net profit | 100.10M | 135.40M | 150.00M | 93.90M | 110.80M | 150.30M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 0.88 | 1.19 | 1.32 | 0.82 | 0.97 | 1.32 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.64B | 1.58B | 1.57B | 1.66B | 1.94B | 2.27B | 2.55B | 2.79B |
| Cash & ST investments | 203.30M | 235.10M | 319.70M | 215.30M | 148.30M | 368.70M | 254.70M | 415.70M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 4.01B | 4.56B | 4.39B | 5.23B | 5.34B | 5.77B | 6.96B | 7.96B |
| Total current liabilities | 893.60M | 1.01B | 987.20M | 1.18B | 1.41B | 1.62B | 1.98B | 2.27B |
| Short-term debt | 48.50M | 166.30M | 154.90M | 182.10M | 187.60M | 248.90M | 305.70M | 434.20M |
| Long-term debt | 885.20M | 814.00M | 634.20M | 1.19B | 1.16B | 974.20M | 1.21B | 1.53B |
| Total liabilities | 2,101,200,000.00 | 2,684,400,000.00 | 2,459,600,000.00 | 3,224,200,000.00 | 3,347,300,000.00 | 3,315,200,000.00 | 4,011,000,000.00 | 4,716,500,000.00 |
| Total equity | 1.91B | 1.88B | 1.93B | 2.00B | 1.99B | 2.45B | 2.95B | 3.24B |
| Retained earnings | 851.20M | 917.70M | 958.60M | 1.04B | 884.00M | 1.10B | 1.37B | 1.75B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.53B | 2.63B | 2.92B | 2.79B | 2.87B | 3.02B |
| Cash & ST investments | 282.80M | 363.70M | 382.30M | 415.70M | 374.20M | 397.30M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 6.94B | 6.97B | 8.12B | 7.96B | 8.04B | 8.19B |
| Total current liabilities | 1.83B | 1.82B | 2.30B | 2.27B | 2.13B | 2.01B |
| Short-term debt | 308.70M | 322.40M | 422.30M | 434.20M | 389.70M | 283.10M |
| Long-term debt | 1.23B | 1.33B | 1.70B | 1.53B | 1.58B | 1.85B |
| Total liabilities | 3,899,500,000.00 | 3,928,700,000.00 | 4,890,500,000.00 | 4,716,500,000.00 | 4,669,300,000.00 | 4,800,300,000.00 |
| Total equity | 3.04B | 3.04B | 3.23B | 3.24B | 3.38B | 3.39B |
| Retained earnings | 1.44B | 1.55B | 1.68B | 1.75B | 1.83B | 1.80B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -- | -- | 603.80M | 397.00M | 304.30M | 520.00M | 603.10M | 862.90M |
| Depreciation & amortization | -- | -- | 228.80M | 221.80M | 283.50M | 283.60M | 318.60M | 351.70M |
| Free cash flow | 38.40M | 392.20M | 569.60M | 346.40M | 229.40M | 419.40M | 504.10M | 791.00M |
| Dividends paid | -61.30M | -64.00M | -68.00M | -72.30M | -78.20M | -84.90M | -94.00M | -101.00M |
| Stock buybacks / issuance | -67.80M | -41.20M | -80.30M | -50.70M | -65.30M | 277.80M | -- | -- |
| Ending cash balance | 185.20M | 204.00M | 284.80M | 186.70M | 148.30M | 352.90M | 228.50M | 398.10M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 100.70M | 134.00M | 315.90M | 312.30M | -2.30M | 118.60M |
| Depreciation & amortization | 78.50M | 79.70M | 90.00M | 103.50M | 94.80M | 93.70M |
| Free cash flow | 84.60M | 115.00M | 301.60M | 289.80M | -23.80M | 98.60M |
| Dividends paid | -23.90M | -25.70M | -25.70M | -25.70M | -25.70M | -27.90M |
| Stock buybacks / issuance | -- | 0 | -- | -- | -- | -175.90M |
| Ending cash balance | 254.00M | 344.50M | 361.50M | 398.10M | 357.70M | 377.30M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 2.49 | 10.28 | 9.00 | 10.21 | 11.52 | 13.14 | 12.68 | 15.50 |
| ROA %i | 1.20 | 4.54 | 3.82 | 4.17 | 4.54 | 5.65 | 5.55 | 6.43 |
| ROIC %i | 2.52 | 7.81 | 6.20 | 6.41 | 7.27 | 9.24 | 9.33 | 10.31 |
| 5-year avg ROE %i | 9.00 | 7.73 | 6.94 | 7.40 | 8.87 | 11.22 | 11.85 | 13.15 |
| EBIT margin %i | 6.02 | 7.02 | 5.70 | 6.68 | 6.95 | 8.18 | 7.77 | 9.15 |
| FCF / sales %i | 0.90 | 8.12 | 12.04 | 7.57 | 4.04 | 6.85 | 6.72 | 9.71 |
| Current ratioi | 1.83 | 1.57 | 1.59 | 1.41 | 1.37 | 1.41 | 1.29 | 1.23 |
| Quick ratioi | 1.76 | 1.52 | 1.53 | 1.37 | 1.33 | 1.37 | 1.25 | 1.20 |
| Debt / assetsi | 23.28 | 34.40 | 29.97 | 36.76 | 34.97 | 29.50 | 29.37 | 32.01 |
| LT debt / equityi | 46.42 | 74.81 | 60.17 | 86.88 | 84.32 | 59.24 | 58.98 | 65.20 |
| Interest coveragei | 8.16 | 4.62 | 5.08 | 7.16 | 5.67 | 5.16 | 4.95 | 6.47 |
| Revenue CAGR (3Y) %i | 14.19 | 3.93 | 5.50 | 2.23 | 5.55 | 11.06 | 17.90 | 12.78 |
| Net income CAGR (3Y) %i | -32.83 | 14.21 | 20.83 | 61.78 | 8.31 | 22.76 | 21.67 | 24.74 |
| FCF CAGR (3Y) %i | -38.35 | 21.29 | 41.84 | 108.17 | -16.37 | -9.70 | 13.32 | 51.08 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 13.04 | 14.54 | 16.22 | 15.50 | 15.28 | 15.69 |
| ROA %i | 5.64 | 6.20 | 6.42 | 6.43 | 6.54 | 6.66 |
| ROIC %i | 9.37 | 9.66 | 10.31 | 10.31 | 10.48 | 10.37 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 7.93 | 8.70 | 9.31 | 9.15 | 9.22 | 9.26 |
| FCF / sales %i | 7.36 | 8.32 | 10.08 | 9.71 | 8.24 | 7.79 |
| Current ratioi | 1.38 | 1.44 | 1.27 | 1.23 | 1.35 | 1.50 |
| Quick ratioi | 1.34 | 1.40 | 1.24 | 1.20 | 1.30 | 1.46 |
| Debt / assetsi | 29.61 | 30.71 | 33.35 | 32.01 | 32.17 | 33.54 |
| LT debt / equityi | 57.45 | 59.77 | 70.77 | 65.20 | 65.13 | 72.64 |
| Interest coveragei | 5.32 | 6.20 | 6.78 | 6.47 | 6.48 | 6.37 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 04:00:07 · For reference only, not investment advice and not tailored to your situation.